Thygeson’s Superficial Punctate Keratitis Medication
There are different types of eye drops commonly used for the treatment of the symptoms of Thygeson’s Superficial Punctate Keratitis. No Thygeson’s Superficial Punctate Keratitis medication is currently available that will cure the eye condition.
Fluorometholone is used to reduce inflammation and neovascularization in the cornea while limiting the movement of polymorphonuclear leukocytes and reversing capillary permeability. This seems to effectively ward off edema, dilation of capillaries, and avoid the scars forming on the patient among other benefits.
Cyclosporine 0.05% is used to mitigate dry eyes, which occur because the patient’s tear production system has been damaged. The typical Cyclosporine ophthalmic eye drops are believed to work as an immunomodulator in part.
Artificial tear lubricates the irritated eyes as it tries to make precorneal tear film thicker and more stable. It is proven to extend the breakup time of tear film. There are other products, such as Refresh Tears, Optive, Systane, Celluvisc, Murine, Tears Naturale, Refresh, GenTeal, and TheraTears, which act in the same way as artificial tears. The products with Hydroxymethylcellulose or Dextran have properties make them last longer, and therefore, do not need to be applied as often. Remember that one of the reasons preservative-free artificial tears is favored over products containing preservatives to avoid some ocular side effects. Talk about these points with your physician before using any product on your eyes.
Keep in mind that products should be thoroughly investigated by the user and not just the doctor or medical team. Be aware of all possible side effects and especially be mindful of anything you are allergic to or have had a bad reaction to in the past.
The idea is to treat the symptoms until the TSPK has gone into remission or your dry eye condition is under control. Some use of the eye drop product after remission may be called for, but it is best used in accordance with the directions.
Thygeson’s Superficial Punctate Keratitis Medication is used by virtually all doctors treating patients and can make a significant difference in a person’s recovery or comfort while in the active state.
Thygeson’s Superficial Punctate Keratitis is also referred to as Thygeson’s Disease, Thygeson’s Syndrome, and Thygeson’s Superficial Punctate Keratopathy.
Suggested Link: http://www.molvis.org/molvis/v15/a155/mv-v15-a155-kawamoto.pdf